Cargando…

Unique molecular signatures of antiviral memory CD8(+) T cells associated with asymptomatic recurrent ocular herpes

The nature of antiviral CD8(+) T cells associated with protective and pathogenic herpes simplex virus type 1 (HSV-1) infections remains unclear. We compared the transcriptome, phenotype, and function of memory CD8(+) T cells, sharing the same HSV-1 epitope-specificities, from infected HLA-A*0201 pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakash, Swayam, Roy, Soumyabrata, Srivastava, Ruchi, Coulon, Pierre-Gregoire, Dhanushkodi, Nisha R., Vahed, Hawa, Jankeel, Allen, Geertsema, Roger, Amezquita, Cassandra, Nguyen, Lan, Messaoudi, Ilhem, Burkhardt, Amanda M., BenMohamed, Lbachir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427992/
https://www.ncbi.nlm.nih.gov/pubmed/32796943
http://dx.doi.org/10.1038/s41598-020-70673-z
Descripción
Sumario:The nature of antiviral CD8(+) T cells associated with protective and pathogenic herpes simplex virus type 1 (HSV-1) infections remains unclear. We compared the transcriptome, phenotype, and function of memory CD8(+) T cells, sharing the same HSV-1 epitope-specificities, from infected HLA-A*0201 positive symptomatic (SYMP) vs. asymptomatic (ASYMP) individuals and HLA-A*0201 transgenic rabbits. Compared to higher frequencies of multifunctional effector memory CD8(+) T(EM) cells in ASYMP individuals, the SYMP individuals presented dysfunctional CD8(+) T(EM) cells, expressing major exhaustion pathways. Compared to protected ASYMP HLA transgenic rabbits, the trigeminal ganglia of non-protected SYMP HLA transgenic rabbits had higher frequencies of dysfunctional tissue-resident CD8(+) T(RM) cells. Moreover, blockade of T cell exhaustion pathways restored the function of CD8(+) T cells, reduced virus reactivation, and diminished recurrent disease in HLA transgenic rabbits. These findings reveal unique molecular signatures of protective CD8(+) T cells and pave the way for T-cell-based immunotherapy to combat recurrent ocular herpes.